<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>22362472</identifier>
<setSpec>1576-6578</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Masjuan, J</dc:author>
<dc:type>Journal Article</dc:type>
<dc:language>es</dc:language>
<dc:date>2012 Mar 01 </dc:date>
<dc:title xml:lang="es">Controversia. Dabigatran en el tratamiento preventivo del ictus embolico: a favor de su utilizacion como farmaco de primera linea.</dc:title>
<dc:title xml:lang="en">[Controversy. Dabigatran in the preventive treatment of embolic stroke: arguments in favour of its utilisation as a first-choice drug].</dc:title>
<dc:publisher>Revista de neurologia</dc:publisher>
</metadata>
</record>
</pubmed-document>
